Hours

Minutes

Seconds

-40%

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oyâ€™s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Companyâ€™s products are used all over the world.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
12/06/26	0.0212 €	0.00%
10/06/26	0.0212 €	0.00%
09/06/26	0.0212 €	0.00%
08/06/26	0.0212 €	0.00%
05/06/26	0.0212 €	0.00%

Real-time BOERSE MUENCHEN

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.0208EUR

Average target price

0.0210EUR

Spread / Average Target

+0.96%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Real-time BOERSE MUENCHEN Other stock markets 03:13:28 12/06/26 am AEST			5-day change	1st Jan Change
0.0212 ^EUR	0.00%		-2.75%	-63.04%

07/06	Bioretec Ltd Announces U.S. Department of Health and Human Services Food and Drug Administration Issues a Final Order	CI
02/06	Bioretec Launches Change Negotiations Across Finnish Production Business	MT

Market Cap	27.91M 32.16M 25.73M 24.11M 45.04M 3.08B 45.98M 307M 119M 1.48B 121M 118M 5.16B	P/E Ratio 2025	-0.07x	P/E Ratio 2026 *	-2.08x
Enterprise Value	23.51M 27.09M 21.67M 20.31M 37.94M 2.59B 38.73M 259M 100M 1.25B 102M 99.51M 4.35B	EV / Sales 2025	6.8x	EV / Sales 2026 *	4.14x
Free-Float	99.48%	Yield 2025 *	-	Yield 2026 *	-

07/06	Bioretec Ltd Announces U.S. Department of Health and Human Services Food and Drug Administration Issues a Final Order	CI
02/06	Bioretec Launches Change Negotiations Across Finnish Production Business	MT
13/05	Bioretec clarifies its 2026-2028 financial target regarding the sales margin	RE
13/05	Bioretec clarifies 2026-2028 financial target regarding sales margin	RE
09/05	Bioretec Ltd Announces Board Changes	CI
27/04	Bioretec Raises EUR13 Million from Rights Offering	MT
25/04	Bioretec says 1.29 bln new shares were subscribed for in rights issue	RE
24/04	Bioretec announces preliminary results from rights issue	RE
21/04	Bioretec Oy Announces Stepping Down of Sarah Van Hellenberg Hubar-Fisher as A Member of the Board of Directors	CI
27/03	Bioretec's Board to Proceed with EUR15 Million Rights Issue	MT
27/03	Bioretec resolves on rights issue of up to about EUR 14.8 mln	RE
27/03	Bioretec Chairman Exempted from Launching Mandatory Takeover Bid	MT
27/03	Bioretec Oy - Finnish FSA grants permanent exemption from mandatory takeover bid to Stephen Industries Inc Oy	RE

04/06	Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher	AQ
02/06	Bioretec Ltd - Manager's transactions - Jordy Winters	AQ
02/06	The Board of Directors of Bioretec Ltd resolved on a new stock option plan	AQ
02/06	Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency	AQ
18/05	Bioretec Ltd - Managers' transactions - Paavola	AQ

Bioretec Oy Stock BOERSE MUENCHEN

Stocks

0TN

FI4000480454

Medical Equipment, Supplies & Distribution

Valuation: Bioretec Oy

Chart: Bioretec Oy

Latest news : Bioretec Oy

Press Releases: Bioretec Oy

Quotes and Performance

Course Extremes

Managers and Directors: Bioretec Oy

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

1 week	-2.75%
Current month	-5.36%
1 month	+73.77%
3 months	-14.57%
6 months	-66.28%
Current year	-63.04%

Manager	Title	Age	Since
Sarah Frances van Hellenberg Hubar-Fisher CEO	Chief Executive Officer	48	15/05/2025
Tuukka Paavola DFI	Director of Finance/CFO	46	20/01/2026
René Eve COO	Chief Operating Officer	-	18/08/2025

Director	Title	Age	Since
David Gill BRD	Director/Board Member	71	08/05/2026
Antti Henrick Alex Vasara BRD	Director/Board Member	61	21/03/2025
Justin Barad BRD	Director/Board Member	-	21/03/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIORETEC OY	0.00%	-2.75%	-86.82%	-89.53%	32.25M
PENUMBRA, INC.	+0.12%	-0.54%	+25.89%	-2.82%	12.56B
ASAHI INTECC CO., LTD.	+1.46%	+5.23%	+63.60%	+41.48%	6.23B
GETINGE AB	-0.89%	-2.98%	-1.31%	-23.66%	5.47B
MINIMED GROUP, INC.	+3.74%	+7.33%	-	-	4.13B
APT MEDICAL INC.	+2.70%	-0.90%	-26.84%	+17.92%	4.05B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-0.51%	-4.24%	-31.12%	-22.90%	3.75B
NOVOCURE LIMITED	+2.04%	-7.00%	-3.63%	-62.17%	1.93B
IMPLANTICA AG	-2.12%	-4.48%	+37.98%	+180.65%	1.69B
NAKANISHI INC.	+0.98%	+5.34%	+62.45%	+4.27%	1.58B
Average	+0.63%	+1.04%	+4.47%	+4.80%	4.6B
Weighted average by Cap.	+0.58%	+0.88%	+17.21%	+7.24%

	2025	2026 *
Net sales	3.8M 4.38M 3.5M 3.28M 6.13M 419M 6.26M 41.78M 16.18M 202M 16.44M 16.08M 703M	5.1M 5.88M 4.7M 4.4M 8.23M 563M 8.4M 56.08M 21.71M 271M 22.06M 21.59M 943M
Net income	-9.6M -11.06M -8.85M -8.29M -15.49M -1.06B -15.81M -106M -40.87M -511M -41.53M -40.63M -1.78B	-7.7M -8.87M -7.1M -6.65M -12.43M -850M -12.68M -84.67M -32.78M -410M -33.31M -32.59M -1.42B
Net Debt	-4.4M -5.07M -4.06M -3.8M -7.1M -485M -7.25M -48.38M -18.73M -234M -19.03M -18.62M -814M	-6.8M -7.84M -6.27M -5.87M -10.97M -750M -11.2M -74.77M -28.95M -362M -29.42M -28.78M -1.26B

1 week	0.02	0.02
1 month	0.01	0.02
3 years	0	0.26